Stock listing
Microba Life Sciences Limited
Selected listing: F3Y · FWB · EUR · DE
Microba Life Sciences Limited (Frankfurt:F3Y), Health Services. Latest release Sep 24, 2026: Appointment of Interim Chief Executive Officer.
- Ticker
- Frankfurt:F3Y
- Asset type
- Stock
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- Frankfurt
- Currency
- EUR
About Microba Life Sciences Limited
The company focuses on advancing microbiome research and developing innovative solutions in the life sciences sector. Microba is dedicated to improving health outcomes through its proprietary technologies and scientific expertise.
Latest news from Microba Life Sciences Limited
Appointment of Interim Chief Executive Officer
September 24, 2026
GSS and MAP agree to Commercial Terms for Merger
September 21, 2026
2026 Annual Report & Appendix 4E
August 30, 2026
Genetic Signatures and Microba in Merger Discussions
August 25, 2026
Q4 FY26 Quarterly Investor Presentation & Webinar
July 15, 2026
Events
Research Microba Life Sciences Limited
Microba Life Sciences Limited company profile
View the public company page for Microba Life Sciences Limited on 6ix.
Microba Life Sciences Limited news
Read company news and market updates connected to Microba Life Sciences Limited.
Microba Life Sciences Limited investor events
Find investor webinars, events, and replay context for Microba Life Sciences Limited.